U.S. Markets closed

AngioSoma Announces New Facility in San Antonio for Diabetes Relief

HOUSTON, TX, April 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma, Inc. (SOAN) announces that Diabetes Relief LLC has licensed a new facility in San Antonio, Texas for its patented treatment, which is about to open. “Diabetes Relief is proud of this facility, which is an important cog in our expansion wheel as we move further west into Texas,” said Dr. Stanley T. Lewis, Chief Medical Officer. “We are anxious to help the thousands of diabetics in the San Antonio area, especially those with foot problems, who may have all but given up hope,” Dr. Lewis added.  

According to the National Institutes of Health, foot problems, especially diabetic neuropathy, are common in people with diabetes. See more at www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/foot-problems. Testimonials from Diabetes Relief’s patients (www.diabetesrelief.com) often include amazing improvements in neuropathy and foot ulcers after receiving the patented treatment.  

The Diabetes Relief protocol treats insulin resistance and improves insulin sensitivity with an approach that is not satisfied with treating only symptoms but goes to the root cause of metabolic disorder, where conventional treatment has failed. Diabetes Relief now has licensed clinics in Texas, Utah, California, Georgia, Florida, Turkey, Azerbaijan and Lebanon, with others planned in the U.S. and abroad.


Diabetes Relief LLC is a privately-held company that began in 2015 with one facility in Houston and has received a letter of intent and is exploring the possibility of a business combination with AngioSoma. Diabetes Relief’s patented process helps patients with all metabolic disorders, dominated by diabetes. Patients report improvements with Diabetes Relief's physiologic insulin administration that they have found nowhere else and with no other treatment or prescription drugs. Its rapidly growing licensees now provide services and products in 5 states and 3 other countries that promote healthier living and an improved quality of life for those living with diabetes and other metabolic dysfunction. Information and patient testimonials are available at www.diabetesrelief.com


AngioSoma, Inc. (https://angiosoma.com), a Nevada corporation based in Houston, Texas, is dedicated to improving the mental and physical wellbeing of men and women. To accomplish that purpose, we are launching a line of supplements under our Somaceuticals™ common identity. Our supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.


Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.


AngioSoma, Inc.
Alex Blankenship
(832) 781-8521